🇺🇸 FDA
Company

Inhibrx

Inhibrx Biosciences

INBX biotech USA

Quick answer

Inhibrx is a biotech company (INBX) headquartered in LA JOLLA, CA, USA with 7 tracked pipeline programs.

Pipeline (7)

project

INBRX-106

Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 3 · small_molecule · active

1 trials project

INBRX-106 - Hexavalent OX40 agonist antibody

Solid Tumor

Phase 2 · small_molecule · active

1 trials project

INBRX-109

Conventional Chondrosarcoma

Phase 2 · small_molecule · active

1 trials project

Pembrolizumab

Triple Negative Breast Cancer

Phase 2 · small_molecule · active

1 trials project

INBRX-101/rhAAT-Fc

Alpha-1 Antitrypsin Deficiency

Phase 1 · small_molecule · completed

1 trials project

INBRX-105 - PDL1x41BB antibody

Metastatic Solid Tumors

Phase 1 · small_molecule · terminated

1 trials project

INBRX-109

Ewing Sarcoma

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12365728

DLL3 single domain antibodies and therapeutic compositions thereof

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12331126

OX40-binding polypeptides and uses thereof

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12331132

Multispecific polypeptide constructs having constrained CD3 binding and related

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12227584

Multivalent and multispecific OX40-binding fusion proteins

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12187804

Multivalent and multispecific 41BB-binding proteins

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12084502

CD33-binding polypeptides and uses thereof

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12043667

CLEC12a binding polypeptides and uses thereof

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12012459

OX40-binding polypeptides and uses thereof

Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)